181 related articles for article (PubMed ID: 9222806)
1. Changes in immunologic variables (TNF-a, sCD8 and sCD4) during danazol treatment in patients with endometriosis.
Matalliotakis I; Neonaki M; Zolindaki A; Hassan E; Georgoulias V; Koumantakis E
Int J Fertil Womens Med; 1997; 42(3):211-4. PubMed ID: 9222806
[TBL] [Abstract][Full Text] [Related]
2. Use of CA-125 in the diagnosis and management of endometriosis: influence of treatment with danazol.
Matalliotakis I; Makrigiannakis A; Karkavitsas N; Psaroudakis E; Froudarakis G; Koumantakis E
Int J Fertil Menopausal Stud; 1994; 39(2):100-4. PubMed ID: 8012438
[TBL] [Abstract][Full Text] [Related]
3. The possible anti-inflammatory role of circulating human leukocyte antigen levels in women with endometriosis after treatment with danazol and leuprorelin acetate depot.
Matalliotakis IM; Athanassakis I; Goumenou AG; Neonaki MA; Koumantakis EE; Vassiliadis S; Koumantakis EE
Mediators Inflamm; 2001 Apr; 10(2):75-80. PubMed ID: 11405553
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of leuprorelin acetate and danazol treatments on serum CA-125 levels in women with endometriosis.
Matalliotakis IM; Arici A; Goumenou AG; Katassos T; Karkavitsas N; Koumantakis EE
Int J Fertil Womens Med; 2004; 49(2):75-8. PubMed ID: 15188832
[TBL] [Abstract][Full Text] [Related]
5. [In vitro effect of danazol on cytokine production of macrophages in peritoneal fluid of infertile patients with endometriosis and its relationship with cytosolic free calicum concentration].
Liu Y; Luo L; Zhao H
Zhonghua Fu Chan Ke Za Zhi; 2000 Aug; 35(8):479-81. PubMed ID: 11776203
[TBL] [Abstract][Full Text] [Related]
6. Three-year follow-up of [CA-125, CA 19-9, CA 15-3, SIL-2R, IL-6, IL-la, TNF-a, sCD8 and sCD4] levels in a woman with severe endometriosis.
Matalliotakis IM; Neonaki MA; Panidis DK; Goumenou AG; Koumantakis EE
Eur J Obstet Gynecol Reprod Biol; 2000 Dec; 93(2):127-9. PubMed ID: 11074131
[TBL] [Abstract][Full Text] [Related]
7. [SHBG serum level in women with endometriosis before, during and after long-term danazol therapy].
Panidis D; Kokkinos T; Vavilis D; Rousso D; Tantanassis T; Kalogeropoulos A
Geburtshilfe Frauenheilkd; 1993 Feb; 53(2):121-4. PubMed ID: 8462828
[TBL] [Abstract][Full Text] [Related]
8. Increase in serum leptin concentrations among women with endometriosis during danazol and leuprolide depot treatments.
Matalliotakis IM; Koumantaki YG; Neonaki MA; Goumenou AG; Koumantakis GE; Kyriakou DS; Koumantakis EE
Am J Obstet Gynecol; 2000 Jul; 183(1):58-62. PubMed ID: 10920309
[TBL] [Abstract][Full Text] [Related]
9. An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis.
Wong AY; Tang L
Fertil Steril; 2004 Jun; 81(6):1522-7. PubMed ID: 15193471
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation of tumor necrosis factor-alpha and interleukin-6 levels in serum and peritoneal fluid of patients with endometriosis].
Li B; Jin F; Yang L
Zhonghua Fu Chan Ke Za Zhi; 2000 Mar; 35(3):166-8. PubMed ID: 11775897
[TBL] [Abstract][Full Text] [Related]
11. [Danazol and its effect on bone and lipid metabolism in patients with endometriosis].
Duque G; Bianchi M; Fernández C; Arteaga E
Rev Chil Obstet Ginecol; 1995; 60(1):34-7. PubMed ID: 8525034
[TBL] [Abstract][Full Text] [Related]
12. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer.
Cottreau CM; Ness RB; Modugno F; Allen GO; Goodman MT
Clin Cancer Res; 2003 Nov; 9(14):5142-4. PubMed ID: 14613992
[TBL] [Abstract][Full Text] [Related]
13. CA 125 levels in monitoring therapy for endometriosis and in prediction of recurrence.
Nagamani M; Kelver ME; Smith ER
Int J Fertil; 1992; 37(4):227-31. PubMed ID: 1354210
[TBL] [Abstract][Full Text] [Related]
14. Soluble serum interleukin-2 receptor, interleukin-6 and interleukin-1a in patients with endometriosis and in controls.
Koumantakis E; Matalliotakis I; Neonaki M; Froudarakis G; Georgoulias V
Arch Gynecol Obstet; 1994; 255(3):107-12. PubMed ID: 7979562
[TBL] [Abstract][Full Text] [Related]
15. PRL, TSH and their response to the TRH test in patients with endometriosis before, during, and after treatment with danazol.
Matalliotakis I; Panidis D; Vlassis G; Vavilis D; Neonaki M; Koumantakis E
Gynecol Obstet Invest; 1996; 42(3):183-6. PubMed ID: 8938471
[TBL] [Abstract][Full Text] [Related]
16. [Clinical remission of colonic endometriosis with danazol: case report and bibliographic considerations].
Kohan MC
Acta Gastroenterol Latinoam; 1996; 26(5):319-21. PubMed ID: 9363272
[TBL] [Abstract][Full Text] [Related]
17. [Levels of soluble CD4 and soluble CD8 in patients with sarcoidosis].
Sato S; Ina Y; Takada K; Sato T; Ito S; Sahashi K; Yamamoto M; Morishita M
Nihon Kyobu Shikkan Gakkai Zasshi; 1994 Feb; 32(2):117-24. PubMed ID: 8164397
[TBL] [Abstract][Full Text] [Related]
18. Danazol treatment of endometriosis-associated pain.
Luciano AA
J Minim Invasive Gynecol; 2006; 13(6):523-4. PubMed ID: 17097573
[No Abstract] [Full Text] [Related]
19. [Changes of tumor necrosis factor alpha and interleukin-6 levels in peritoneal fluid of patients with endometriosis and their effects on human sperm motility and mouse embryo development].
Liu Y; Luo L; Zhao H
Zhonghua Fu Chan Ke Za Zhi; 2000 Jun; 35(6):332-4. PubMed ID: 11776171
[TBL] [Abstract][Full Text] [Related]
20. [Medical treatment of endometriosis: comparative study of leuprolide acetate and danazol].
Palagiano A; Capuano V
Minerva Ginecol; 1994 Apr; 46(4):173-7. PubMed ID: 8065590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
